
Explore gene delivery technologies by comparing viral, non-viral, and chemical strategies for in vivo and ex vivo transfer of Crispr and genetic constructs, including germline versus somatic considerations.
Explore in vivo and ex vivo gene therapy strategies, from liposome and biolistic delivery to recombinant viruses like AAV, lentivirus, and adenovirus.
Explore replication-defective lentiviral, AAV, and adenoviral vectors for safe gene delivery, focusing on packaging, tissue tropism, and immunogenicity.
Explore viral delivery technologies, including retroviral and lentiviral vectors with integration and insertional mutagenesis risks, compare adenovirus, AAV, and herpes simplex virus, and contrast with non-viral and ex vivo strategies.
Explore non wireless physical gene transfer strategies, including naked DNA, plasmid DNA, intramuscular injection, microinjection, electroporation, sonoporation, and magnetofection, highlighting delivery and expression with safety trade-offs.
Master chemical gene transfer technologies using biocompatible, low-toxicity carriers to deliver DNA or RNA. Explore lipoplexes, polyplexes, liposomes, dendrimers, and inorganic nanoparticles for non-viral gene delivery.
Gene therapy is a unique technique that uses the gene to prevent or cure any disease. The gene therapy technique could allow doctors to treat a disorder by inserting a gene into a patient's cell instead of using drugs or surgery. Some researchers and physicians are examining a variety of approaches to gene therapy, including i) replacing a disease-causing mutated gene with a healthy gene; ii) "knocking out" or inactivating a misoperated mutated gene, and iii) introducing new genes into cells for protection from any disease.
Gene delivery systems are essential for gene therapy of human genetic diseases. Gene therapy is the unique way to use the adjustable gene to treat any disease. Gene therapy is one of the promising treatments for a number of diseases such as inherited disorders, viral infection, and cancers. The beneficial results of gene delivery systems depend on the opening of tunable targeting gene delivery systems. Some successful gene delivery systems have been recently reported for the practical application of gene therapy. Recent advances in viral gene delivery systems and non-viral gene delivery systems for gene therapy are briefly reviewed. Viral gene delivery systems are discussed for viral vectors based on DNA, RNA, and oncolytic viral vectors. Non-viral gene delivery systems have also been treated with physicochemical approaches such as physical methods and chemical methods. Several types of successful gene delivery systems are briefly discussed on the basis of gene delivery systems such as cationic polymers, poly(L-lysine), polysaccharides, and poly(ethyleneimine).
•Viral transmission Strategies
•Lentiviral, Adeno-associated virus
•Adenoviral, Retroviral, Herpes Simplex virus
•Physical transfer strategies
•Naked/plasmid DNA, Ballistic DNA injection, Electroporation,
•Hydrodynamic and ultrasound transmission technologies
•Chemical transfer technologies
•Inorganic particles (Calcium phosphate, gold, magnetic)
•Synthetic organic particles (Polymers, Encapsulation, Liposome, lipid biocompatible transfer)